ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

NCI CTEP Approved Trials For the Month of March

March 29, 2013

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

Henschke Responds To Articles On I-ELCAP.

January 12, 2007